NCT05712967View on ClinicalTrials.gov

Role of the Host Microbiota and Il-17 in Favoring Multiple Myeloma Progression

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

June 14, 2019

Primary Completion Date

February 5, 2024

Study Completion Date

February 5, 2024

Conditions
Multiple Myeloma
Trial Locations (1)

20132

IRCCS Ospedale San Raffaele, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER

NCT05712967 - Role of the Host Microbiota and Il-17 in Favoring Multiple Myeloma Progression | Biotech Hunter | Biotech Hunter